Skip to main content

Table 4 Complications between AML and ALL

From: Alternative donor peripheral blood stem cell transplantation for the treatment of high-risk refractory and/or relapsed childhood acute leukemia: a randomized trial

Group aGVHD Grade II-IVaGVHD cGVHD IPFD Hemorrhagic cystitis EBV infection CMV infection
AML (n, %) 23 (39) 6 (10.2) 12 (20.3) 17 (28.8) 15 (25.4) 9 (15.3) 22 (37.3)
ALL (n, %) 21 (40.4) 8 (15.4) 13 (25) 18 (34.6) 18 (34.6) 18 (34.6) 26 (50)
P 1 0.568 0.651 0.545 0.307 0.026 0.186
  1. GVHD graft-versus-host disease, IPFD invasive pulmonary fungal disease, EBV Epstein–Barr virus, CMV cytomegalovirus